Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
50.09
+0.60 (1.21%)
At close: Apr 30, 2026, 4:00 PM EDT
50.77
+0.68 (1.36%)
After-hours: Apr 30, 2026, 7:47 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $29.69 billion as of April 30, 2026. Its market cap has increased by 59.53% in one year.
Market Cap
29.69B
Enterprise Value
38.03B
1-Year Change
59.53%
Ranking
Category
Stock Price
$50.09
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $29.69B, an increase of 12.08%. That is a compound annual growth rate of 1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 28.55B | 27.99% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 48.73B |
| Alnylam Pharmaceuticals | 41.29B |
| BeOne Medicines AG | 32.81B |
| Revolution Medicines | 30.31B |
| Insmed | 29.43B |
| BioNTech SE | 26.16B |
| Roivant Sciences | 20.42B |
| Incyte | 19.03B |